Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series
Background: Acute myocardial infarction (AMI) complicated by cardiogenic shock (AMI-CS) or heart failure is associated with an unacceptably high in-hospital mortality of 33%–55% and a lost chance to accept PCI (Percutaneous Coronary Intervention). Aim: The aim of the study was to find out whether pe...
Gespeichert in:
| Veröffentlicht in: | Perfusion 2023-01, Vol.38 (1), p.208-213 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 213 |
|---|---|
| container_issue | 1 |
| container_start_page | 208 |
| container_title | Perfusion |
| container_volume | 38 |
| creator | Bhat, Rafiq Ahmed Ali, Syed Manzoor Rathi, Akanksha Bhat, Javaid Akhter Iqbal, Raja Saqib Islam, Md Monowarul Maqbool, Syed Tibrewal, Abhishek Qu, Yongsheng Zhang, You Sun, Yuxiao Xiao, Wentao Gao, Chuanyu |
| description | Background:
Acute myocardial infarction (AMI) complicated by cardiogenic shock (AMI-CS) or heart failure is associated with an unacceptably high in-hospital mortality of 33%–55% and a lost chance to accept PCI (Percutaneous Coronary Intervention).
Aim:
The aim of the study was to find out whether percutaneous hemodynamic support device Impella 2.5 improves prognosis of high-risk PCI patients or not.
Methods:
This study was a case series involving six patients who underwent a Left Ventricular Assist Device (LVAD, Impella 2.5, Abiomed, Danvers, MA) implantation after suffering from AMI with a very low ejection fraction and acute heart failure. The clinical experience and outcomes of the patients are hereby discussed.
Results:
All PCI procedures were safely completed under LVAD support. The hemodynamic parameters of all patients improved clinically over the next 30 days and following 12 months after Impella insertion except in two patients, of which one patient (Case number 6) died 4 days post-Impella protected PCI procedure due to acute left ventricle heart failure with cardiogenic shock and pulmonary oedema; and another one died at 12 months after Impella protected PCI procedure (Case number 4) due to decompensated heart failure and infected pneumonia.
Conclusion:
Percutaneous hemodynamic support is favorable and feasible during high risk Percutaneous Coronary Intervention (PCI). A bigger study is needed to substantiate the claims of the current study. |
| doi_str_mv | 10.1177/02676591211049018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2577458251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_02676591211049018</sage_id><sourcerecordid>2765295535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-e9bf24c9360d2ca0ca7b06f72811aa20c52cdd479f0994cf35b5e06da67158133</originalsourceid><addsrcrecordid>eNp1kU9LAzEQxYMoWqsfwIsEvHhwayabbLrepPinINSDgrclzc7WlW5Sk13Bb2_WVgXFUw7zey_z5hFyBGwEoNQ545nKZA4cgImcwXiLDEAolQDA0zYZ9POkB_bIfggvjDEhRLpL9lIhx5AxNSBh1rXGNUhdRafNCpdLTflI0i4grS1d6bZG2wba2RL9wtV2Qe_Rm67VFl0X6MR5Z7V_p1Pbon-LbO1sr7xFq-0ZnTzXVl9QTY2OjgF9jeGA7FR6GfBw8w7J4_XVw-Q2uZvdTCeXd4lJOWsTzOcVFyZPM1Zyo5nRas6ySvExgNacGclNWQqVVyzPhalSOZfIslJnCmK8NB2S07XvyrvXDkNbNHUwfcTP3QsulYqH4BIievILfXGdt3G7gscT81zKVEYK1pTxLgSPVbHydRPTF8CKvpHiTyNRc7xx7uYNlt-KrwoiMFoDQS_w59v_HT8Aa36SIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2765295535</pqid></control><display><type>article</type><title>Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Bhat, Rafiq Ahmed ; Ali, Syed Manzoor ; Rathi, Akanksha ; Bhat, Javaid Akhter ; Iqbal, Raja Saqib ; Islam, Md Monowarul ; Maqbool, Syed ; Tibrewal, Abhishek ; Qu, Yongsheng ; Zhang, You ; Sun, Yuxiao ; Xiao, Wentao ; Gao, Chuanyu</creator><creatorcontrib>Bhat, Rafiq Ahmed ; Ali, Syed Manzoor ; Rathi, Akanksha ; Bhat, Javaid Akhter ; Iqbal, Raja Saqib ; Islam, Md Monowarul ; Maqbool, Syed ; Tibrewal, Abhishek ; Qu, Yongsheng ; Zhang, You ; Sun, Yuxiao ; Xiao, Wentao ; Gao, Chuanyu</creatorcontrib><description>Background:
Acute myocardial infarction (AMI) complicated by cardiogenic shock (AMI-CS) or heart failure is associated with an unacceptably high in-hospital mortality of 33%–55% and a lost chance to accept PCI (Percutaneous Coronary Intervention).
Aim:
The aim of the study was to find out whether percutaneous hemodynamic support device Impella 2.5 improves prognosis of high-risk PCI patients or not.
Methods:
This study was a case series involving six patients who underwent a Left Ventricular Assist Device (LVAD, Impella 2.5, Abiomed, Danvers, MA) implantation after suffering from AMI with a very low ejection fraction and acute heart failure. The clinical experience and outcomes of the patients are hereby discussed.
Results:
All PCI procedures were safely completed under LVAD support. The hemodynamic parameters of all patients improved clinically over the next 30 days and following 12 months after Impella insertion except in two patients, of which one patient (Case number 6) died 4 days post-Impella protected PCI procedure due to acute left ventricle heart failure with cardiogenic shock and pulmonary oedema; and another one died at 12 months after Impella protected PCI procedure (Case number 4) due to decompensated heart failure and infected pneumonia.
Conclusion:
Percutaneous hemodynamic support is favorable and feasible during high risk Percutaneous Coronary Intervention (PCI). A bigger study is needed to substantiate the claims of the current study.</description><identifier>ISSN: 0267-6591</identifier><identifier>EISSN: 1477-111X</identifier><identifier>DOI: 10.1177/02676591211049018</identifier><identifier>PMID: 34581607</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Angioplasty ; Congestive heart failure ; Edema ; Heart failure ; Heart Failure - complications ; Heart Failure - surgery ; Heart-Assist Devices - adverse effects ; Hemodynamics ; Humans ; Myocardial infarction ; Myocardial Infarction - etiology ; Patients ; Percutaneous Coronary Intervention - adverse effects ; Retrospective Studies ; Shock, Cardiogenic - complications ; Shock, Cardiogenic - surgery ; Stents ; Treatment Outcome ; Ventricle ; Ventricular assist devices</subject><ispartof>Perfusion, 2023-01, Vol.38 (1), p.208-213</ispartof><rights>The Author(s) 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c320t-e9bf24c9360d2ca0ca7b06f72811aa20c52cdd479f0994cf35b5e06da67158133</cites><orcidid>0000-0001-7079-2283 ; 0000-0003-1149-7190</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/02676591211049018$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/02676591211049018$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34581607$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhat, Rafiq Ahmed</creatorcontrib><creatorcontrib>Ali, Syed Manzoor</creatorcontrib><creatorcontrib>Rathi, Akanksha</creatorcontrib><creatorcontrib>Bhat, Javaid Akhter</creatorcontrib><creatorcontrib>Iqbal, Raja Saqib</creatorcontrib><creatorcontrib>Islam, Md Monowarul</creatorcontrib><creatorcontrib>Maqbool, Syed</creatorcontrib><creatorcontrib>Tibrewal, Abhishek</creatorcontrib><creatorcontrib>Qu, Yongsheng</creatorcontrib><creatorcontrib>Zhang, You</creatorcontrib><creatorcontrib>Sun, Yuxiao</creatorcontrib><creatorcontrib>Xiao, Wentao</creatorcontrib><creatorcontrib>Gao, Chuanyu</creatorcontrib><title>Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series</title><title>Perfusion</title><addtitle>Perfusion</addtitle><description>Background:
Acute myocardial infarction (AMI) complicated by cardiogenic shock (AMI-CS) or heart failure is associated with an unacceptably high in-hospital mortality of 33%–55% and a lost chance to accept PCI (Percutaneous Coronary Intervention).
Aim:
The aim of the study was to find out whether percutaneous hemodynamic support device Impella 2.5 improves prognosis of high-risk PCI patients or not.
Methods:
This study was a case series involving six patients who underwent a Left Ventricular Assist Device (LVAD, Impella 2.5, Abiomed, Danvers, MA) implantation after suffering from AMI with a very low ejection fraction and acute heart failure. The clinical experience and outcomes of the patients are hereby discussed.
Results:
All PCI procedures were safely completed under LVAD support. The hemodynamic parameters of all patients improved clinically over the next 30 days and following 12 months after Impella insertion except in two patients, of which one patient (Case number 6) died 4 days post-Impella protected PCI procedure due to acute left ventricle heart failure with cardiogenic shock and pulmonary oedema; and another one died at 12 months after Impella protected PCI procedure (Case number 4) due to decompensated heart failure and infected pneumonia.
Conclusion:
Percutaneous hemodynamic support is favorable and feasible during high risk Percutaneous Coronary Intervention (PCI). A bigger study is needed to substantiate the claims of the current study.</description><subject>Angioplasty</subject><subject>Congestive heart failure</subject><subject>Edema</subject><subject>Heart failure</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - surgery</subject><subject>Heart-Assist Devices - adverse effects</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Myocardial infarction</subject><subject>Myocardial Infarction - etiology</subject><subject>Patients</subject><subject>Percutaneous Coronary Intervention - adverse effects</subject><subject>Retrospective Studies</subject><subject>Shock, Cardiogenic - complications</subject><subject>Shock, Cardiogenic - surgery</subject><subject>Stents</subject><subject>Treatment Outcome</subject><subject>Ventricle</subject><subject>Ventricular assist devices</subject><issn>0267-6591</issn><issn>1477-111X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU9LAzEQxYMoWqsfwIsEvHhwayabbLrepPinINSDgrclzc7WlW5Sk13Bb2_WVgXFUw7zey_z5hFyBGwEoNQ545nKZA4cgImcwXiLDEAolQDA0zYZ9POkB_bIfggvjDEhRLpL9lIhx5AxNSBh1rXGNUhdRafNCpdLTflI0i4grS1d6bZG2wba2RL9wtV2Qe_Rm67VFl0X6MR5Z7V_p1Pbon-LbO1sr7xFq-0ZnTzXVl9QTY2OjgF9jeGA7FR6GfBw8w7J4_XVw-Q2uZvdTCeXd4lJOWsTzOcVFyZPM1Zyo5nRas6ySvExgNacGclNWQqVVyzPhalSOZfIslJnCmK8NB2S07XvyrvXDkNbNHUwfcTP3QsulYqH4BIievILfXGdt3G7gscT81zKVEYK1pTxLgSPVbHydRPTF8CKvpHiTyNRc7xx7uYNlt-KrwoiMFoDQS_w59v_HT8Aa36SIQ</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Bhat, Rafiq Ahmed</creator><creator>Ali, Syed Manzoor</creator><creator>Rathi, Akanksha</creator><creator>Bhat, Javaid Akhter</creator><creator>Iqbal, Raja Saqib</creator><creator>Islam, Md Monowarul</creator><creator>Maqbool, Syed</creator><creator>Tibrewal, Abhishek</creator><creator>Qu, Yongsheng</creator><creator>Zhang, You</creator><creator>Sun, Yuxiao</creator><creator>Xiao, Wentao</creator><creator>Gao, Chuanyu</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7079-2283</orcidid><orcidid>https://orcid.org/0000-0003-1149-7190</orcidid></search><sort><creationdate>20230101</creationdate><title>Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series</title><author>Bhat, Rafiq Ahmed ; Ali, Syed Manzoor ; Rathi, Akanksha ; Bhat, Javaid Akhter ; Iqbal, Raja Saqib ; Islam, Md Monowarul ; Maqbool, Syed ; Tibrewal, Abhishek ; Qu, Yongsheng ; Zhang, You ; Sun, Yuxiao ; Xiao, Wentao ; Gao, Chuanyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-e9bf24c9360d2ca0ca7b06f72811aa20c52cdd479f0994cf35b5e06da67158133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Angioplasty</topic><topic>Congestive heart failure</topic><topic>Edema</topic><topic>Heart failure</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - surgery</topic><topic>Heart-Assist Devices - adverse effects</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Myocardial infarction</topic><topic>Myocardial Infarction - etiology</topic><topic>Patients</topic><topic>Percutaneous Coronary Intervention - adverse effects</topic><topic>Retrospective Studies</topic><topic>Shock, Cardiogenic - complications</topic><topic>Shock, Cardiogenic - surgery</topic><topic>Stents</topic><topic>Treatment Outcome</topic><topic>Ventricle</topic><topic>Ventricular assist devices</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhat, Rafiq Ahmed</creatorcontrib><creatorcontrib>Ali, Syed Manzoor</creatorcontrib><creatorcontrib>Rathi, Akanksha</creatorcontrib><creatorcontrib>Bhat, Javaid Akhter</creatorcontrib><creatorcontrib>Iqbal, Raja Saqib</creatorcontrib><creatorcontrib>Islam, Md Monowarul</creatorcontrib><creatorcontrib>Maqbool, Syed</creatorcontrib><creatorcontrib>Tibrewal, Abhishek</creatorcontrib><creatorcontrib>Qu, Yongsheng</creatorcontrib><creatorcontrib>Zhang, You</creatorcontrib><creatorcontrib>Sun, Yuxiao</creatorcontrib><creatorcontrib>Xiao, Wentao</creatorcontrib><creatorcontrib>Gao, Chuanyu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Perfusion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhat, Rafiq Ahmed</au><au>Ali, Syed Manzoor</au><au>Rathi, Akanksha</au><au>Bhat, Javaid Akhter</au><au>Iqbal, Raja Saqib</au><au>Islam, Md Monowarul</au><au>Maqbool, Syed</au><au>Tibrewal, Abhishek</au><au>Qu, Yongsheng</au><au>Zhang, You</au><au>Sun, Yuxiao</au><au>Xiao, Wentao</au><au>Gao, Chuanyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series</atitle><jtitle>Perfusion</jtitle><addtitle>Perfusion</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>38</volume><issue>1</issue><spage>208</spage><epage>213</epage><pages>208-213</pages><issn>0267-6591</issn><eissn>1477-111X</eissn><abstract>Background:
Acute myocardial infarction (AMI) complicated by cardiogenic shock (AMI-CS) or heart failure is associated with an unacceptably high in-hospital mortality of 33%–55% and a lost chance to accept PCI (Percutaneous Coronary Intervention).
Aim:
The aim of the study was to find out whether percutaneous hemodynamic support device Impella 2.5 improves prognosis of high-risk PCI patients or not.
Methods:
This study was a case series involving six patients who underwent a Left Ventricular Assist Device (LVAD, Impella 2.5, Abiomed, Danvers, MA) implantation after suffering from AMI with a very low ejection fraction and acute heart failure. The clinical experience and outcomes of the patients are hereby discussed.
Results:
All PCI procedures were safely completed under LVAD support. The hemodynamic parameters of all patients improved clinically over the next 30 days and following 12 months after Impella insertion except in two patients, of which one patient (Case number 6) died 4 days post-Impella protected PCI procedure due to acute left ventricle heart failure with cardiogenic shock and pulmonary oedema; and another one died at 12 months after Impella protected PCI procedure (Case number 4) due to decompensated heart failure and infected pneumonia.
Conclusion:
Percutaneous hemodynamic support is favorable and feasible during high risk Percutaneous Coronary Intervention (PCI). A bigger study is needed to substantiate the claims of the current study.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>34581607</pmid><doi>10.1177/02676591211049018</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7079-2283</orcidid><orcidid>https://orcid.org/0000-0003-1149-7190</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0267-6591 |
| ispartof | Perfusion, 2023-01, Vol.38 (1), p.208-213 |
| issn | 0267-6591 1477-111X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2577458251 |
| source | MEDLINE; SAGE Complete |
| subjects | Angioplasty Congestive heart failure Edema Heart failure Heart Failure - complications Heart Failure - surgery Heart-Assist Devices - adverse effects Hemodynamics Humans Myocardial infarction Myocardial Infarction - etiology Patients Percutaneous Coronary Intervention - adverse effects Retrospective Studies Shock, Cardiogenic - complications Shock, Cardiogenic - surgery Stents Treatment Outcome Ventricle Ventricular assist devices |
| title | Outcome of Impella 2.5 use in patients undergoing Percutaneous Coronary Intervention in Henan, China: a case series |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T10%3A57%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcome%20of%20Impella%202.5%20use%20in%20patients%20undergoing%20Percutaneous%20Coronary%20Intervention%20in%20Henan,%20China:%20a%20case%20series&rft.jtitle=Perfusion&rft.au=Bhat,%20Rafiq%20Ahmed&rft.date=2023-01-01&rft.volume=38&rft.issue=1&rft.spage=208&rft.epage=213&rft.pages=208-213&rft.issn=0267-6591&rft.eissn=1477-111X&rft_id=info:doi/10.1177/02676591211049018&rft_dat=%3Cproquest_cross%3E2765295535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2765295535&rft_id=info:pmid/34581607&rft_sage_id=10.1177_02676591211049018&rfr_iscdi=true |